29507054 |
Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors
Hansson, J,
Peeper, DS,
Nielsen, J,
Seashore-Ludlow, B,
Tuominen, R,
Caramuta, S,
Altun, M,
Azimi, A,
Maddalo, G,
Edfors, F,
Boström, J,
Uhlén, M,
Robinson, JL,
Kemper, K,
Krijgsman, O,
Egyhazi Brage, S
|
Mol Syst Biol |
2018 |
15607961 |
Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF
Golub, TR,
Widlund, HR,
Nishimura, EK,
Fisher, DE,
Ramaswamy, S,
Ross, K,
Huber, WE,
Horstmann, MA,
Du, J
|
Cancer Cell |
2004 |